Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT07260825
PHASE2/PHASE3

Use of Topical Testosterone and Estrogen vs Estrogen Alone in Vulvodynia: a Randomized Controlled Trial

Sponsor: TriHealth Inc.

View on ClinicalTrials.gov

Summary

We are looking to see if patients using both topical testosterone and estrogen will have a greater improvement in pain with vaginal penetration compared to those using topical estrogen alone.

Key Details

Gender

FEMALE

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

44

Start Date

2025-12

Completion Date

2026-08

Last Updated

2025-12-03

Healthy Volunteers

No

Interventions

DRUG

Estradiol 0.01% Vag Cream

0.01% Estradiol cream, 1g to be applied to the vestibule twice daily for 12 weeks

DRUG

testosterone 0.1% and estradiol 0.01% vaginal cream

0.01% Estradiol and 0.1% testosterone cream, apply 1g to the vestibule twice daily for 12 weeks

Locations (2)

Cincinnati Urogynecology Associates

Cincinnati, Ohio, United States

TriHealth

Cincinnati, Ohio, United States